Cargando…

How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion

Anterior cervical discectomy and fusion (ACDF) is performed to relieve pain caused by degenerative disk disease and nerve obstruction. As an alternative to bone graft, autologous concentrated bone marrow aspirate (CBMA) is used to achieve vertebral fusion with a satisfactory success rate. This has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaput, Christopher D., Shar, Adam, Jupiter, Daniel, Hubert, Zach, Clough, Bret, Krause, Ulf, Gregory, Carl A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152872/
https://www.ncbi.nlm.nih.gov/pubmed/30248138
http://dx.doi.org/10.1371/journal.pone.0203714
_version_ 1783357442796552192
author Chaput, Christopher D.
Shar, Adam
Jupiter, Daniel
Hubert, Zach
Clough, Bret
Krause, Ulf
Gregory, Carl A.
author_facet Chaput, Christopher D.
Shar, Adam
Jupiter, Daniel
Hubert, Zach
Clough, Bret
Krause, Ulf
Gregory, Carl A.
author_sort Chaput, Christopher D.
collection PubMed
description Anterior cervical discectomy and fusion (ACDF) is performed to relieve pain caused by degenerative disk disease and nerve obstruction. As an alternative to bone graft, autologous concentrated bone marrow aspirate (CBMA) is used to achieve vertebral fusion with a satisfactory success rate. This has been attributed in part to bone marrow-resident mesenchymal stromal cells (MSCs) with the capacity to differentiate into osteoblasts and generate bone tissue. To date, there has been no study comparing cellular yields, MSC frequencies and their osteogenic potential with ACDF outcome. Patients (n = 24) received ACDF with CBMA and allograft bone matrix. Colony forming unit fibroblast (CFU-F) and CFU-osteoblasts (CFU-O) assays were performed on CBMA samples to enumerate MSCs (CFU-F) and osteogenic MSCs (CFU-O). CFUs were normalized to CBMA volume to define yield and also to mononuclear cells (MNC) to define frequency. After 1-year, fusion rates were good (86.7%) with pain and disability improved. There was a negative relationship between MNC and CFU-F measurements with age of patient and CFU-Os negatively correlated with age in females but not males. Tobacco use did not affect CBMA but was associated with poorer clinical outcome. Surprisingly, we found that while high-grade fusion was not associated with CFU-O, it correlated strongly (p<0.0067) with CBMA containing the lowest frequencies of CFU-F (3.0x10(-6)–5.83x10(-5) CFU-F/MNC). MNC levels alone were not responsible for the results. These observations suggest that osteogenesis by human bone marrow is controlled by homeostatic ratio of MSCs to other cellular bone marrow components rather than absolute level of osteogenic MSCs, and that a lower ratio of MSCs to other cellular components in marrow tends to predict effective osteogenesis during ACDF. The results presented herein challenge the current dogma surrounding the proposed mechanism of MSCs in bone healing.
format Online
Article
Text
id pubmed-6152872
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-61528722018-10-19 How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion Chaput, Christopher D. Shar, Adam Jupiter, Daniel Hubert, Zach Clough, Bret Krause, Ulf Gregory, Carl A. PLoS One Research Article Anterior cervical discectomy and fusion (ACDF) is performed to relieve pain caused by degenerative disk disease and nerve obstruction. As an alternative to bone graft, autologous concentrated bone marrow aspirate (CBMA) is used to achieve vertebral fusion with a satisfactory success rate. This has been attributed in part to bone marrow-resident mesenchymal stromal cells (MSCs) with the capacity to differentiate into osteoblasts and generate bone tissue. To date, there has been no study comparing cellular yields, MSC frequencies and their osteogenic potential with ACDF outcome. Patients (n = 24) received ACDF with CBMA and allograft bone matrix. Colony forming unit fibroblast (CFU-F) and CFU-osteoblasts (CFU-O) assays were performed on CBMA samples to enumerate MSCs (CFU-F) and osteogenic MSCs (CFU-O). CFUs were normalized to CBMA volume to define yield and also to mononuclear cells (MNC) to define frequency. After 1-year, fusion rates were good (86.7%) with pain and disability improved. There was a negative relationship between MNC and CFU-F measurements with age of patient and CFU-Os negatively correlated with age in females but not males. Tobacco use did not affect CBMA but was associated with poorer clinical outcome. Surprisingly, we found that while high-grade fusion was not associated with CFU-O, it correlated strongly (p<0.0067) with CBMA containing the lowest frequencies of CFU-F (3.0x10(-6)–5.83x10(-5) CFU-F/MNC). MNC levels alone were not responsible for the results. These observations suggest that osteogenesis by human bone marrow is controlled by homeostatic ratio of MSCs to other cellular bone marrow components rather than absolute level of osteogenic MSCs, and that a lower ratio of MSCs to other cellular components in marrow tends to predict effective osteogenesis during ACDF. The results presented herein challenge the current dogma surrounding the proposed mechanism of MSCs in bone healing. Public Library of Science 2018-09-24 /pmc/articles/PMC6152872/ /pubmed/30248138 http://dx.doi.org/10.1371/journal.pone.0203714 Text en © 2018 Chaput et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chaput, Christopher D.
Shar, Adam
Jupiter, Daniel
Hubert, Zach
Clough, Bret
Krause, Ulf
Gregory, Carl A.
How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion
title How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion
title_full How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion
title_fullStr How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion
title_full_unstemmed How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion
title_short How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion
title_sort how stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152872/
https://www.ncbi.nlm.nih.gov/pubmed/30248138
http://dx.doi.org/10.1371/journal.pone.0203714
work_keys_str_mv AT chaputchristopherd howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion
AT sharadam howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion
AT jupiterdaniel howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion
AT hubertzach howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion
AT cloughbret howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion
AT krauseulf howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion
AT gregorycarla howstemcellcompositioninbonemarrowaspiraterelatestoclinicaloutcomeswhenusedforcervicalspinefusion